Antibacterial and antifungal drug discovery: companies are racing to keep pace with the emergence of drug-resistant microorganisms
Article Abstract:
Infectious diseases causes by bacteria and fungi plague millions of people worldwide, and in the US alone cost in excess of $20 billion annually.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Cardiovascular disease: prognostic/diagnostic testing and a raft of new drug targets from genomics promise to transform cardiovascular medicine
Article Abstract:
Cardiovascular disease cause 15 million deaths in the world each year.They account for 50% of deaths in the developed world.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Entremed's stock seesaws
Article Abstract:
Bristol-Myers Squibb returned to Entremed the anti-angiogenesis compound, angiostatin, for more research and development.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Web marketers wrestle with content control: companies starting to implement site posting strategies. c2o's mission: EDS' Web shop aims to merge fragmented online commerce solutions
- Abstracts: Comment on Fried, Lovell, and Yaisawarng. Evaluating the performance of US credit unions. The impact of mergers on credit union service provision
- Abstracts: Similarities and contradictions in the core logic of three strategy research streams. Strategy research: governance and competence perspectives
- Abstracts: Joint ventures: theoretical and empirical perspectives. Do firms learn to create value? The case of alliances
- Abstracts: Drug discovery--an operating model for a new era. Drug approval in Europe. EU's new orphan drug regulations